Department of Defense Pharamacy Uniform Formulary Blanket Purchase Agreement/Uniform... Tender

DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) has floated a tender for Department of Defense Pharamacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program. The project location is USA and the tender is closing on 30 Jul 2025. The tender notice number is HT9402-25-Q-9304, while the TOT Ref Number is 123105328. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country: USA

Summary: Department of Defense Pharamacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Deadline: 30 Jul 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 123105328

Document Ref. No.: HT9402-25-Q-9304

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description

The Department of Defense (DoD) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.

P&T COMMITTEE MEETING: The following August 2025 newly approved drugs will be reviewed:

a. Andembry-Corticosteroids-Immune Modulators-Hereditary Angioedema Agentsb. Arbli - Renin-Angiotensin Antihypertensives - Angiotensin II Receptor Blockersc. Avmapki Fakzynja Co-pack - Oncological Agents - NAd. Ensacove - Oncological Agents - NAe. Ibtrozi - Oncological Agents - NAf. Imuldosa - Targeted Immunomodulatory Biologics - IL-23g. Khindivi - Corticosteroids-Immune Modulators - NAh. Merilog - Insulins - Rapid-Acting Agentsi. nilotinib tartrate-Oncological Agents-Chronic Myelogenous Leukemiaj. Tryptyr - Ophthalmic - Dry Eyek. ustekinumab-aekn - Targeted Immunomodulatory Biologics - IL-23l. Yutrepia - Pulmonary Arterial Hypertension - Prostacyclin Nebulizedm. Zelsuvmi -A...
Active Contract Opportunity
Notice ID : HT9402-25-Q-9304
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE HEALTH AGENCY (DHA)
Office: DEFENSE HEALTH AGENCY
General Information
Contract Opportunity Type: Solicitation (Updated)
Updated Published Date: Jul 21, 2025 12:14 pm CDT
Original Published Date: Jul 10, 2025 09:40 am CDT
Updated Date Offers Due: Jul 30, 2025 12:00 pm CDT
Original Date Offers Due: Jul 28, 2025 12:00 pm CDT
Inactive Policy: Manual
Updated Inactive Date: Jan 30, 2026
Original Inactive Date: Jan 28, 2026
Initiative: None

Classification
Original Set Aside: No Set aside used

Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Place of Performance: San Antonio, Tx 78230 USA

Documents

 Tender Notice

A0001-HT9402-25-Q-9304.pdf

A0001-RFQ-HT9402-25-Q-9304-NAD.pdf

A0001-Price-List-Andembry-Corticosteroids-Immune.xlsx

A0001-Price-List-Arbli-Renin-Angiotensin-Antih.xlsx

A0001-Price-List-Avmapki-Fakzynja-Co-pack-Onco.xlsx

A0001-Price-List-Ensacove-Oncological-Agents.xlsx

A0001-Price-List-Ibtrozi-Oncological-Agents.xlsx

A0001-Price-List-Imuldosa-TIB-IL-23.xlsx

A0001-Price-List-Khindivi-Corticosteroids-Immu.xlsx

A0001-Price-List-Merilog-Insulins-Rapid-Acti.xlsx

A0001-Price-List-nilotinib-tartrate-Oncological.xlsx

A0001-Price-List-Tryptyr-Ophthalmic-Dry-Eye.xlsx

A0001-Price-List-ustekinumab-aekn-TIB-IL-23.xlsx

A0001-Price-List-Yutrepia-Pulmonary-Arterial-H.xlsx

A0001-Price-List-Zelsuvmi-Antiinfectives-Misc.xlsx

RFQ-HT9402-25-Q-9304-NAD.pdf

A-1-Price-List-Andembry-Corticosteroids-Immune-Mod.xlsx

A-1-Price-List-Arbli-Renin-Angiotensin-Antihyp.xlsx

A-1-Price-List-Avmapki-Fakzynja-Co-pack-Oncolo.xlsx

A-1-Price-List-Ensacove-Oncological-Agents-N.xlsx

A-1-Price-List-Ibtrozi-Oncological-Agents-NA.xlsx

A-3-Price-List-Imuldosa-TIB-IL-23.xlsx

A-1-Price-List-Khindivi-Corticosteroids-Immune.xlsx

A-1-Price-List-Merilog-Insulins-Rapid-Acting.xlsx

A-1-Price-List-nilotinib-tartrate-Oncological-Agen.xlsx

A-3-Price-List-Tryptyr-Ophthalmic-Dry-Eye.xlsx

A-1-Price-List-ustekinumab-aekn-Targeted-Immun.xlsx

A-1-Price-List-Yutrepia-Pulmonary-Arterial-Hyp.xlsx

A-1-Price-List-Zelsuvmi-Antiinfectives-Miscel.xlsx

Price-Appendix-FAQ-NAD.pdf

DoD-Formulary-Placement-of-FDA-Newly-Approved-Drug.pdf


Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA


Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?